VYNE icon

VYNE Therapeutics

104 hedge funds and large institutions have $138M invested in VYNE Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.39M
2 +$3.31M
3 +$946K
4
Squarepoint
Squarepoint
New York
+$791K
5
State Street
State Street
Massachusetts
+$783K

Top Sellers

1 -$1.39M
2 -$581K
3 -$352K
4
Morgan Stanley
Morgan Stanley
New York
-$251K
5
SSA
Schonfeld Strategic Advisors
New York
-$233K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$122K
52
$119K
53
$105K
54
$105K
55
$105K
56
$97K
57
$92K
58
$86K
59
$79K
60
$79K
61
$72K
62
$69K
63
$64K
64
$64K
65
$57K
66
$55K
67
$54K
68
$53K
69
$52K
70
$52K
71
$40K
72
$40K
73
$39K
74
$39K
75
$37K